Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

International Journal of Endocrinology
Volume 2016, Article ID 5872423, 10 pages
http://dx.doi.org/10.1155/2016/5872423
Research Article

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents

1Department of Psychiatry, School of Medical Sciences (FCM), State University of Campinas (Unicamp), 13083-887 Campinas, SP, Brazil
2Laboratory of Human Genetics, Center for Molecular Biology and Genetic Engineering (CBMEG), Unicamp, 13083-875 Campinas, SP, Brazil
3Growth and Development Laboratory, Center for Investigation in Pediatrics (CIPED), FCM-Unicamp, 13083-887 Campinas, SP, Brazil
4Department of Pediatrics, Pediatric Endocrinology Unit, FCM-Unicamp, 13083-887 Campinas, SP, Brazil

Received 26 August 2015; Revised 11 December 2015; Accepted 20 December 2015

Academic Editor: Javier Salvador

Copyright © 2016 Amilton Dos Santos-Júnior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Amilton Dos Santos-Júnior, Taciane Barbosa Henriques, Maricilda Palandi de Mello, et al., “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents,” International Journal of Endocrinology, vol. 2016, Article ID 5872423, 10 pages, 2016. https://doi.org/10.1155/2016/5872423.